home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  NEURODEGENERATION in Alzheimer's Disease, Parkinson's Disease, & Related Disorders  
  May 14, 2001

Biotechnology

 
     
  Strategic Research Institute, Hyatt Regency Hotel, Princeton, NJ
July 23-24, 2001


FEATURING:
ALZHEIMER'S B-SECRETASE PROTEIN BACE 1: A TARGET FOR TREATMENT OF ALZHEIMER'S DISEASE-DR. MARTIN CITRON, AMGEN, INC.
THE EVOLUTION OF NEURAL AND STEM CELL THERAPIES FOR PARKINSON'S DISEASE-DR. OLE ISACSON, HARVARD MEDICAL SCHOOL
DEVELOPMENT OF RADIOLIGLANDS FOR IN VIVO IMAGING OF BRAIN AMYLOID-DR. VIRGINIA M.-Y. LEE, UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE
GALANTAMINE: CRESULTS FROM THE CLINICAL DEVELOPMENT PROGRAM-DR. SEAN LILIENFELD, JANSSEN RESEARCHN FOUNDATION
ORGANIZED INTO SIX SECTIONS
-PARKINSON'S DISEASE
-NOVEL THERAPEUTIC TARGETS IN NEURODEGENERATION
-PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE
-AMYLOID PROCESSING
-NOVEL THERAPEUTIC TARGETS IN NEURODEGENERATION
-THERAPEUTIC ADVANCES
 
 
Organized by: sri
Invited Speakers: AMGEN, INC., JANSSEN RESEARCH FOUNDATION, AVENTIS PHARMACEUTICALS, UNIVERSITY OF PENNSYLVANIA, NEOTHERAPEUTICS, INC., HARVARD MEDICAL SCHOOL, THE R.W. JOHNSON PRI, NEW YORK MEDICAL CENTER, BINZOU PEOPLE'S HOSPITAL, BRIGHAM AND WOMEN'S HOSPITAL, MITOKOR, NEUROCHEM, INC., JOHNS HOPKINS UNIVERSITY, LILLY RESEARCH LABORATORIES, EXELIS, INC., GUILFORD PHARMACEUTICALS, ACADIA PHARMACEUTICALS.
 
Deadline for Abstracts: ABSTRACTS HAVE ALREADY BEEN SUBMITTED
 
Registration: TO REGISTER CALL 1-888-666-8514
E-mail: ESINGLETON@SRINSTITUTE.COM
 
  Posted by:   edrilon  
Host: 12.3.58.10
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.